86-08-8
Chemical Structure
3-Acetylpyridine adenine dinucleotide, 90%
Synonym(s): 3-APAD, 90%; 3-Acetylpyridine NAD, 90%
- CAS No.: 86-08-8
- Formula:C22H28N6O14P2
- Molecular Weight:662.44
IUPAC Name: 3-acetyl-1-((2R,3R,4S,5R)-5-((((((((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)pyridin-1-ium
InChIKey: KPVQNXLUPNWQHM-RBEMOOQDSA-N
SMILES: O[C@H]1[C@](O[C@@H]([C@H]1O)COP(OP(OC[C@H]2O[C@]([N+]3=CC=CC(C(C)=O)=C3)([H])[C@@H]([C@@H]2O)O)([O-])=O)(O)=O)([H])N4C5=NC=NC(N)=C5N=C4
Biological Activity: 3-Acetylpyridine adenine dinucleotide, 90% is an analog of nicotinamide adenine dinucleotide (NAD). 33-Acetylpyridine adenine dinucleotide, 90% collaboratively inhibits Lactate Dehydrogenase (LDH) with bisulfite[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
3-Acetylpyridine adenine dinucleotide, 90% | 94.45% | 3-Acetylpyridine adenine dinucleotide, 90% is an analog of nicotinamide adenine dinucleotide (NAD). 33-Acetylpyridine adenine dinucleotide, 90% collaboratively inhibits Lactate Dehydrogenase (LDH) with bisulfite. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
3-Acetylpyridine adenine dinucleotide, 95% | 95.07% | 3-Acetylpyridine adenine dinucleotide, 95% (3-APAD, 95%)is an analog of nicotinamide adenine dinucleotide (NAD). 33-Acetylpyridine adenine dinucleotide, 95% collaboratively inhibits Lactate Dehydrogenase (LDH) with bisulfite. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Boland MJ. NADH-dependent glutamate synthase from lupin nodules. Reactions with oxidised and reduced 3-acetylpyridine-adenine dinucleotide. Eur J Biochem. 1981 Apr;115(3):485-9. [Content Brief]
- [2]. Ciaccio EI. The inhibition of lactate dehydrogenase by 3-acetylpyridine adenine dinucleotide and bisulfite. J Biol Chem. 1966 Apr 10;241(7):1581-6. [Content Brief]
